Publication:
Neurotrophin-3 provides neuroprotection via TrkC receptor dependent pErk5 activation in a rat surgical brain injury model

dc.contributor.coauthorAkyol, Onat
dc.contributor.coauthorSherchan, Prativa
dc.contributor.coauthorYilmaz, Gokce
dc.contributor.coauthorReis, Cesar
dc.contributor.coauthorHo, Wingi Man
dc.contributor.coauthorWang, Yuechun
dc.contributor.coauthorHuang, Lei
dc.contributor.coauthorZhang, John H.
dc.contributor.departmentN/A
dc.contributor.kuauthorSolaroğlu, İhsan
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid102059
dc.date.accessioned2024-11-10T00:11:51Z
dc.date.issued2018
dc.description.abstractBackground: Surgical brain injury (SBI) which occurs due to the inadvertent injury inflicted to surrounding brain tissue during neurosurgical procedures can potentiate blood brain barrier (BBB) permeability, brain edema and neurological deficits. This study investigated the role of neurotrophin 3 (NT-3) and tropomyosin related kinase receptor C (TrkC) against brain edema and neurological deficits in a rat SBI model. Methods: SBI was induced in male Sprague Dawley rats by partial right frontal lobe resection. Temporal expression of endogenous NT-3 and TrkC was evaluated at 6, 12, 24 and 72 h after SBI. SBI rats received recombinant NT-3 which was directly applied to the brain surgical injury site using gelfoam. Brain edema and neurological function was evaluated at 24 and 72 h after SBI. Small interfering RNA (siRNA) for TrkC and Rap1 was administered via intracerebroventricular injection 24 h before SBI. BBB permeability assay and western blot was performed at 24 h after SBI. Results: Endogenous NT-3 was decreased and TrkC expression increased after SBI. Topical administration of recombinant NT-3 reduced brain edema, BBB permeability and improved neurological function after SIR Recombinant NT-3 administration increased the expression of phosphorylated Rap1 and Erk5. The protective effect of NT-3 was reversed with TrkC siRNA but not Rap1 siRNA. Conclusions: Topical application of NT-3 reduced brain edema, BBB permeability and improved neurological function after SBI. The protective effect of NT-3 was possibly mediated via TrkC dependent activation of Erk5.
dc.description.indexedbyWoS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipNIH [NS084921] This study was partially supported by NIH grant NS084921 to JHZ.
dc.description.volume307
dc.identifier.doi10.1016/j.expneurol.2018.06.002
dc.identifier.eissn1090-2430
dc.identifier.issn0014-4886
dc.identifier.quartileQ1
dc.identifier.scopus2-s2.0-85048065570
dc.identifier.urihttp://dx.doi.org/10.1016/j.expneurol.2018.06.002
dc.identifier.urihttps://hdl.handle.net/20.500.14288/17557
dc.identifier.wos439956000009
dc.keywordsSurgical brain injury
dc.keywordsBrain edema
dc.keywordsNeurotrophin 3
dc.keywordsTropomyosin related kinase receptor C
dc.keywordsExtracellular signal related kinase 5
dc.languageEnglish
dc.publisherAcademic Press Inc Elsevier Science
dc.sourceExperimental Neurology
dc.subjectNeurosciences
dc.titleNeurotrophin-3 provides neuroprotection via TrkC receptor dependent pErk5 activation in a rat surgical brain injury model
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.authorid0000-0002-9472-1735
local.contributor.kuauthorSolaroğlu, İhsan

Files